Digital treatment map for ALK- and ROS1-mutated NSCLC

EVALUATION Thank you for your feedback! × Dismiss alert Welcome to our Digital Treatment Map A practical, expert-led, and evidence-based resource designed to help you navigate the different treatment lines of ALK and ROS1 mutation positive NSCLC. Join Dr Barbara Melosky, Dr Solange Peters, and Dr Ross Camidge as they guide you through this independent […]

Urothelial Cancer

Home Case studies Expert interviews eLearning Clinical trial summary News Portuguese Translation Treatment options for metastatic urothelial carcinoma Urothelial carcinoma is one of the most common malignancies worldwide. This innovative program comprises a suite of educational resources for those managing patients with metastatic urothelial carcinoma (mUC), having a particular focus on the use of immunotherapy […]

Enriched treatment pathway for type 2 diabetes

Welcome to our Enriched Treatment Pathway – an expert-led practical and evidence-based tool designed help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). You have immediate access to expert opinion and the latest data and evidence, with practical guidance on how to incorporate learning and knowledge into your […]

Treating Metastatic Renal Cell Carcinoma

Treating metastatic renal cell carcinoma: Patient case studies The development of several targeted treatment options has revolutionized the treatment of metastatic RCC.  Dr Axel Merseburger invites you to participate in this three-part case study series which looks at how to manage metastatic renal cell carcinoma (RCC). In the first case study, we follow a good prognosis […]

Pathway tool

Access our new interactive and instructional tool, designed to help you navigate the different treatment lines of non-driver NSCLC. It is targeted at international (medical and radiation) oncologists and any other healthcare professionals involved in the diagnosis, treatment, and follow-up of patients with lung cancer. Select your region: North America Europe Asia North America Launch […]

MMPAD

A message from the Programme Director… With diagnoses of type 1 diabetes in Europe on the rise, healthcare professionals face increasing challenges in the prevention and management of paediatric diabetes as well as keeping on top of the latest research. In partnership with Springer Healthcare IME, I am delighted to present this European-wide set of […]

Targeting improved outcomes in EGFR-mutated NSCLC

Webcast Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Pathway Follow a patient’s progression using this interactive pathway as we support your clinical treatment decision-making supported by trial data and expert opinion. An expert-driven program addressing the optimal treatment strategy for patients […]